These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19170854

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A 6-month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Middle Eastern and North African men with erectile dysfunction.
    El-Meliegy A, Rabah D, Al-Mitwalli K, Mostafa T, Hussein T, Istarabadi M, Lei Y, Gurbuz S.
    Curr Med Res Opin; 2013 Jun; 29(6):707-17. PubMed ID: 23540436
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E, Porst H, Kim ED, Montorsi F, Hackett G, Morales AM, Stuckey B, Būttner H, West TM, Huynh NN, Lenero E, Burns P, Kopernicky V.
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
    Fugl-Meyer KS, Stothard D, Belger M, Toll A, Berglund O, Eliasson T, Fugl-Meyer AR.
    Int J Clin Pract; 2006 Nov; 60(11):1386-93. PubMed ID: 17073836
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S.
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [Abstract] [Full Text] [Related]

  • 33. The efficacy of tadalafil in clinical populations.
    Lewis RW, Sadovsky R, Eardley I, O'Leary M, Seftel A, Wang WC, Shen W, Walker DJ, Wong DG, Ahuja S.
    J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
    [Abstract] [Full Text] [Related]

  • 34. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM, Hague JA, Ahuja S.
    J Androl; 2005 Jul; 26(3):310-8. PubMed ID: 15866997
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J.
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily.
    Seftel AD, Buvat J, Althof SE, McMurray JG, Zeigler HL, Burns PR, Wong DG.
    Int J Impot Res; 2009 Nov; 21(4):240-8. PubMed ID: 19536128
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.